Stephen Tulipano - Former CFO at Stoke Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Former CFO
Stock Symbol
STOK on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

Stephen Tulipano - trading volume in the past year for Stoke Therapeutics, Inc.

Holdings reported by Stephen Tulipano for Stoke Therapeutics, Inc.

Class Num Shares Value Price $ Report Date Ownership Underlying Class Underlying Amount
Restricted Stock Units 40,000 $631 K $15.78 Mar 27, 2024 Direct Common Stock
Common Stock 20,746 $127 K $6.10 Mar 19, 2024 Direct
Employee Stock Option (Right to Buy) 60,000 Mar 27, 2024 Direct Common Stock

Transactions reported by Stephen Tulipano for Stoke Therapeutics, Inc.

Sym Class Transaction % Value $ Price $ Shares Shares After Date Ownership